Ajay Rai, MBA

VP, Business Development

Ajay brings more than 20 years of finance, strategy and business development/M&A experience to his role at Frequency. Previously, Ajay was Senior Director of Corporate Development for Takeda, where he was responsible for evaluating and leading M&A, divestments, joint ventures and new company formation.

Ajay spent more than 10 years at Biogen in a variety of roles including business planning, investor relations, corporate strategy, venture investment and business development/M&A. While there, he was responsible for leading business development activities for several therapeutic areas including immunology, pain and tissue injury, and fibrosis. He completed more than 15 transactions ranging from acquisitions to early-stage research partnerships. He was also instrumental in leading new and follow-on investments in multiple early-stage companies for Biogen’s Venture Portfolio.

Before joining Biogen, Ajay was an M&A advisor for Ernst & Young’s M&A advisory practice. He started his career in the Finance and Strategy Group of Roche Molecular Systems. He has been an advisor to multiple start-up life sciences companies including Innovate Biopharma, Immunomic Therapeutics and Cayuga Therapeutics. Ajay earned a B.S. in Finance from New York University’s Stern School of Business and a M.B.A. from Case Western University.